Ocular pharmacokinetics of 0.45% ketorolac tromethamine

PURPOSE: A new carboxymethylcellulose (CMC)-containing ophthalmic formulation of 0.45% ketorolac, pH 6.8 (Acuvail(®)) was recently developed for treatment of inflammation and pain after cataract surgery. This study compared pharmacokinetics of the new formulation with that of a prior formulation, 0....

Descripción completa

Detalles Bibliográficos
Autores principales: Attar, Mayssa, Schiffman, Rhett, Borbridge, Lisa, Farnes, Quinn, Welty, Devin
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2999556/
https://www.ncbi.nlm.nih.gov/pubmed/21179226
http://dx.doi.org/10.2147/OPTH.S15146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2999556/
https://www.ncbi.nlm.nih.gov/pubmed/21179226
http://dx.doi.org/10.2147/OPTH.S15146

Ejemplares similares